Mutations in the tail of the cytoplasmic dynein molecule have been reported to cause neurodegenerative disease in mice. The mutant mouse strain Legs at odd angles (Loa) has impaired retrograde axonal transport, but the molecular deficiencies in the mutant dynein molecule, and how they contribute to neurodegeneration, are unknown. To address these questions, we purified dynein from wild-type mice and the Legs at odd angles mutant mice. Using biochemical, single-molecule, and live-cell-imaging techniques, we find a marked inhibition of motor run-length in vitro and in vivo, and significantly altered motor domain coordination in the dynein from mutant mice. These results suggest a potential role for the dynein tail in motor function, and provide direct evidence for a link between single-motor processivity and disease.
Mutations in the tail of the cytoplasmic dynein molecule have been reported to cause neurodegenerative disease in mice. The mutant mouse strain Legs at odd angles (Loa) has impaired retrograde axonal transport, but the molecular deficiencies in the mutant dynein molecule, and how they contribute to neurodegeneration, are unknown. To address these questions, we purified dynein from wild-type mice and the Legs at odd angles mutant mice. Using biochemical, single-molecule, and live-cell-imaging techniques, we find a marked inhibition of motor run-length in vitro and in vivo, and significantly altered motor domain coordination in the dynein from mutant mice. These results suggest a potential role for the dynein tail in motor function, and provide direct evidence for a link between single-motor processivity and disease.
Cytoplasmic dynein is a minus-end directed microtubule motor protein responsible for a variety of cellular functions, including retrograde axonal transport 1 . Two dynein mutant mouse strains, Legs at odd angles (Loa) and Cramping1 (Cra1), were identified in a screen for genes involved in late onset motor neuron disease (MND) 2 . This finding identified a new class of MND genes (including the p150Glued gene, which encodes for a subunit of dynactin, a protein of the dynein regulatory complex [3] [4] [5] ; Dctn1 in mice and DCTN1 in humans), and significantly expanded the limited pool of familial amyotrophic lateral sclerosis (ALS) candidate genes. Of the dynein mutations, Loa has received particular attention [6] [7] [8] [9] [10] . Loa +/mice were initially reported to exhibit lower motor neuron degeneration, but recent studies have found severe loss of sensory neurons 8, 9 . Loa mutant mice also exhibited a decreased rate of retrograde axonal transport 2, 10 . The Loa mutation (F580Y) resides in the amino-terminal region of the dynein heavy chain polypeptide, within the dynein 'tail' . This region is responsible for organizing the multiple dynein subunits into a complex and for binding to membranous cargo. Dynein generates force through its two motor domains, each located at the carboxy-terminal end of the heavy chain, 1,500 amino acids (15-20 nm) from the site of the Loa mutation. Whether and how the Loa mutation affects cytoplasmic dynein function has remained untested.
To approach this problem, we first tested the ability of dynein to remain associated with membranous vesicles isolated by sucrose step gradient flotation from the brains of wild-type, Loa +/and Loa -/mice. No clear difference could be detected (Fig. 1a ). The Loa mutation lies in the region of the dynein heavy chain involved in heavy chain-heavy chain dimerization and in heavy chain-intermediate chain binding ( Supplementary Information, Fig. S1 ). We therefore tested for potential defects in the stability of the mutant complex. Fractionation of whole brain cytosol by sucrose density gradient centrifugation revealed a single major 20S dynein peak for both the wild-type and Loa +/mutant animals. In contrast, dynein from Loa -/mice demonstrated a small, but reproducible, decrease in dynein S value, accompanied by the appearance of a free intermediate-chain peak (12 ± 2% of total intermediate chains) at 6S ( Supplementary Information, Fig. S2a ). To test whether these observations reflect a more general reduction in mutant dynein stability, we exposed brain extracts to potassium iodide (KI), a chaotropic salt to which dynein is particularly sensitive 11 . In the presence of KI, dynein dissociation increased both as a function of KI concentration and the proportion of mutant dynein heavy chain (Supplementary Information, Fig. S2b-d) . These results indicate that the Loa mutation may impair the interactions between subunits.
To gain further insight into the molecular effects of the Loa mutation, we purified cytoplasmic dynein from wild-type and Loa +/adult mouse brains 1 . As observed in brain cytosol, the purified mutant dynein remained intact by sucrose density gradient centrifugation (data not shown). The dynein purified from Loa +/mice had no differences in subunit composition when compared with the wild-type mouse protein, and neither preparation had detectable levels of the processivity factor dynactin, as assessed by Coomassie-blue staining and immunoblotting ( Fig. 1b and Supplementary Information, Fig. S3a, b ). As mice homozygous for the Loa mutation die shortly after birth, the amounts of brain tissue we could obtain were inadequate to purify biochemical amounts of dynein by this procedure. Nonetheless, we were able to purify small amounts of dynein from Loa -/mice for single molecule analysis using a modification of this method (Figs 2 and 3 and Supplementary Information, Fig. S3c, d ).
L E T T E R S
To test the effects of the Loa mutation on dynein mechanochemical activity, we measured the ATPase activity of dynein purified from wildtype and Loa +/mice in the presence and absence of microtubules. The basal ATPase activity was similar for dynein from both wild-type and Loa +/mice: 51.3 ± 5.3 and 51.7 ± 3.3 nmol Pi min -1 per mg of dynein, respectively ( Fig. 1c ). However, in the presence of microtubules, the ATPase activities of wild-type and mutant dynein differed markedly. The Michaelis constant for microtubules, K mMT , was 1.5 ± 0.2 μM for the purified wild-type dynein, similar to the value for bovine cytoplasmic dynein 12 , whereas the K mMT for dynein from Loa +/mice was significantly higher, 11.8 ± 3.4 μM (P < 0.001). In contrast, the maximum rate (V max ) values were similar (wild-type = 255 ± 9 nmol min -1 per mg; Loa +/-= 263 ± 43 nmol min -1 per mg). The latter results indicate that the maximal ATP turnover rate is unaffected by the Loa mutation. However, the increased K mMT suggests a marked decrease in the effective affinity of the mutant dynein for microtubules during ATP hydrolysis. In support of this, the K mMT for dynein from Loa +/mice was partially rescued at reduced ionic strength (4.0 ± 0.6 μM, compared with 1.2 ± 0.2 μM for wild-type), which increases the affinity of dynein for microtubules 12 . Furthermore, microtubule binding by the purified mutant dynein was markedly reduced, compared with wild-type dynein, in the presence of ATP, but not in its absence (apo state; Fig. 1d ). From this surprising result, it seems that much of the dynein fraction normally seen to co-sediment with microtubules in the presence of ATP is engaged in active, processive movement along the microtubule. These results suggest that the Loa mutation affects the interaction of dynein with microtubules during the ATPase and force-generating portion of the crossbridge cycle, but not in the strong microtubule-binding (apo) state.
To gain insight into the underlying molecular defects of dynein from Loa mutants, we used quantum-dot and optical-trap assays under single-molecule conditions. Wild-type and mutant dynein were attached to quantum dots using antibodies specific to the dynein tail, and the velocity and run-length of these particles was then analysed. Movements in the two dynein preparations were ATP-dependent and at a velocity similar to that reported for mouse dynein-dynactin complexes ( Fig. 2a and Supplementary Information, Fig. S4a ) 13 . The purified wild-type and mutant dyneins had predominantly unidirectional movements, but some bidirectional events were also observed, as previously reported (Fig. 2c) [13] [14] [15] . However, a clear difference was observed in the wild-type versus mutant dynein run-lengths ( Fig. 2b, c) . Wild-type dynein had an average run-length of 339 ± 33 nm ( Fig. 2c ), about half that of mouse dyneindynactin complexes 13 (consistent with the absence of dynactin in our dynein preparations). Dynein from Loa +/mice had fewer long runs and a 23% shorter average run-length (259 ± 9 nm). Dynein from Loa -/mice was even more impaired, with an average run-length approximately half that of wild-type dynein (175 ± 4 nm; Fig. 2c ). Optical-trap experiments using the same dynein preparations adsorbed to polystyrene beads gave comparable results. There was no difference in the average velocity, but there was a similar reduction in the single-motor processivity, of dynein from Loa +/mice, compared with dynein from wild-type mice ( Fig. 3a and Supplementary Information, Fig. S4b, c) . Based on the motility data, we calculate a 31% and 37% increase in the average off-rate, at 0.5 mM and 1 mM ATP, respectively, for dynein from Loa +/mice, compared with wild-type dynein (Supplementary Information). This is consistent with the enhanced dissociation of Loa +/--mouse dynein from microtubules in the presence of ATP ( Fig. 1 ). Consistent with results for bovine cytoplasmic dynein, the stall force for single wild-type-mouse dynein molecules was 1.4 ± 0.3 pN, and within experimental error of the forces measured for dynein from Loa +/mice (1.7 ± 0.4 pN) and Loa -/mice (1.6 ± 0.4 pN; Fig. 3b ) 14, 16 . We also observed no difference in the step size of the wild-type or mutant dynein motors while they moved along microtubules under load ( Fig. 3c and Supplementary Information, Fig. S5a -c). Physiological cargoes typically use multiple motors. To assess how the observed defects in dynein processivity translate to the in vivo condition, we measured the run-lengths of wild-type and Loa mutant dyneins in vitro and found an increase in run-length for multi-motor conditions (as previously reported in ref. 17 ). However, this increase was attenuated for dynein from Loa +/mice ( Fig. 3d ). Computational modelling of Optical-trap analysis of wild-type and mutant cytoplasmic dynein dynamics in single-and multi-motor regions. The fraction of beads bound to microtubules was used as an indicator for the average number of available motors per bead: ≤ 30% corresponds to single-motor levels and > 50% to multiple-motor levels (Supplementary Information). Dyneincoated beads were positioned on a microtubule using an optical trap.
(a) Distribution of run velocities for beads attached to dynein isolated from wild-type or Loa +/mice. The mean velocity ± s.e.m. is indicated for dynein isolated from each mouse strain (n = 110 and 135 runs for dynein isolated from wild-type and Loa +/mice, respectively; P = 0.97).
(b) Representative single-motor stall force traces for dynein purified from mice with the indicated genotypes. After positioning of the dyneinbound beads on a microtubule, a trap stiffness of 2.2 pN per 100 nm was applied. A stall was scored if the bead proceeded away from the trap centre and held its plateau position for > 200 ms before detachment. The mean stalling force ± s.d. is indicated for dynein isolated from each mouse strain (n = 29, 34 and 51 stalls for wild type, Loa +/and Loa −/dynein, respectively). The standard deviations from the mean for the stall forces are consistent with the systematic noise of the optical trap, 0.3-0.4 pN.
(c) Distribution of axial step sizes for beads bound to dynein, purified from wild-type and Loa +/mice, under 2.2 pN per 100 nm applied load (n = 7269 and 1979 axial steps for wild-type and Loa +/dynein, respectively, P = 0.89). The two peaks represent both forward and backward stepping for dynein isolated from wild-type and Loa +/mice. The bulk of steps larger than 8 nm in both directions represent unresolved, consecutive 8 nm steps (see Supplemental Information). (d) Run-lengths of beads were measured at the indicated bead-microtubule binding fractions. Data are means ± s.e.m. Wild-type: n = 38, 64 and 127 runs for binding fraction of 50, 75, and 100%, respectively; Loa +/-: n = 39 and 296 runs for binding fraction of 75 and 100%, respectively. Asterisks indicate P < 0.03). Loa +/run-length at 50% binding fraction was below measurement limit under assay conditions used here ( Supplementary Information, Fig. S4c ).
dynein run-lengths at more extensive motor:cargo ratios demonstrated that the mean travel defect persisted with up to three or more dynein molecules per cargo, with and without adding the potential effects of in vivo factors into the simulation, such as the presence of dynactin 13, 18, 19 (Fig. 4b, top and Supplementary Information, Fig. S6a, b ). An additional consequence of decreased single-molecule processivity is a reduction in the number of instantaneously engaged motors per cargo in the multiple motor range, which in turn further limits cargo travel ( Supplementary  Information, Fig. S6b ). These simulations reveal a previously unappreciated sensitivity of multiple-motor run-lengths to changes in single-motor processivity, which is especially apparent here where the single-motor processivity is low, compared with bovine dynein.
The Loa mutation has been linked to defects in retrograde axonal transport 2 . To compare the effects of the Loa mutation in vivo with our in vitro data, we performed live-cell imaging analysis of lysosome/late endosome dynamics at high temporal resolution (5 frames s -1 ; Fig. 4a -c). Custom analysis software was then used to precisely identify periods of uninterrupted motion ('runs' , for definition see Supplemental Information) towards the cell body. The far distal region of the axon was imaged (> 100 μm from cell body) and predominantly unidirectional, retrograde runs were observed, as previously described 20 . Retrograde run-lengths were reduced by 53% and 83% in neurons from Loa +/and Loa -/mice, respectively (P < 0.001, Fig. 4b , bottom and Supplementary Information, Fig. S6c ). The wild-type in vivo run-length (5.27 ± 0.34 μm) allowed us to use the simulated data shown in Figure 4b to estimate an average of 7.7 dynein molecules per cargo, similar to recent values based on stall force and biochemical isolation 21, 22 . We then predicted the expected mutant run-lengths with 7.7 dyneins per cargo, adjusting only the single-motor processivity to reflect the measured in vitro processivity defects. The predicted run-lengths were in excellent agreement with those measured in vivo (2.49 ± 0.13 versus 2.43 ± 0.21 μm for dynein from Loa +/mice; 0.89 ± 0.05 versus 0.86 ± 0.07 μm for Loa -/mice; Fig. 4b, bottom) . No difference was found in the instantaneous velocity of lysosomes when comparing wild-type with Loa mutant neurons ( Fig. 4c, left) , which is consistent with the in vitro experiments (Figs 2a and 3a) . However, the average velocity was reduced by 22% in Loa +/and 43% in Loa -/neurons when compared with wild-type ( Fig. 4c, right) , consistent with an increase in run terminations, and comparable to theoretical prediction (11% decrease in average velocity for dynein from Loa +/mice and 37% for dynein from Loa -/mice; Supplementary Information). These results suggest that the Loa dynein processivity defect identified in vitro can account for the observed impairment in retrograde axonal transport. To gain further insight into the mechanism responsible for altered Loa dynein processivity, we tested for the reported tendency of cytoplasmic dynein to step laterally on the microtubule surface, in contrast to the strict linear travel of kinesin 15, 23 . Lateral stepping was confirmed in mouse dynein, and furthermore, there was a significant increase in its frequency for the mutant protein from Loa +/mice (Fig. 5a, b) . One potential explanation for this result is a disrupted coordination between the two motor domains within the native dynein complex. A gating mechanism between dimeric motor domains is well established for kinesins and myosins, but is not well understood for dynein [24] [25] [26] . Gating contributes to processive motion by ensuring that, as one motor domain advances, the other remains strongly associated with its track in the apo state, thereby preventing premature detachment 26 . As a test for altered gating in the Loa mutant dynein, we measured its Michaelis L E T T E R S constant for ATP, K mATP . Despite the somewhat decreased V max for Loa +/-mouse dynein because of its higher K mMT (Fig. 1c ), the K mATP was clearly decreased (18.8 ± 4.1 μM, compared with 27.0 ± 6.5 μM for wild-type, P < 0.05; Fig. 5c ). This result is consistent with a defect in communication between motor domains, allowing premature ATP binding by the apo motor domain, and subsequent release from the microtubule (Fig. 5d ).
Further kinetic analysis will be needed to confirm this model. These results have implications for intramolecular regulation of cytoplasmic dynein motor activity. Despite the location of the Loa mutation within the dynein tail, we find several lines of evidence for an altered interaction between dynein and microtubules, which is direct evidence for communication between the dynein motor and tail domains. The clear defect we observed in mutant dynein processivity raises the possibility of motor domain miscoordination. Supporting this, we identified novel defects in the Loa-mutant dynein: both an increase in lateral stepping on the microtubule lattice, and an increased affinity for ATP that apparently leads to premature run termination. Consistent with the subtly decreased stability of the Loa-mutant dynein complex, we propose that an abnormal linkage within the base of the Loa-mutant dynein molecule disrupts coordination between the two motor domains by altering their relative positioning and ability to interact laterally.
These results also suggest a role for processivity defects in disease causation. Neurodegeneration in the Loa +/mutant mouse is unlikely to result from dynein subunit dissociation, as no dissociation was detected for the Loa +/complex in cytosolic extracts or following purification (only dynein from the Loa -/mouse, which dies shortly after birth, shows evidence of dissociation; Supplementary Information, Fig. S2 ). The data also argue against a loss in the association of dynein with membranous cargo, which persisted in our biochemical analysis. The most marked change observed to result from the Loa mutation was a decrease in dynein run-length. This effect quantitatively accounted for the observed defect in axonal transport, as indicated by a combination of empirical analysis with computational modelling. The neurons that are most likely to be affected by this defect in processivity and impairment in transport would be those with the longest axons, such as motor and sensory neurons. Our study therefore provides the first evidence that altered motor protein processivity can have pronounced consequences for in vivo transport, the impairment of which clearly correlates with neuronal death and disease.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturecellbiology/ DOI: 10.1038/ncb2127
M E T H O D S
METHODS Protein purification. Cytoplasmic dynein was purified from the brains of wildtype-and Loa +/--adult mice by microtubule-affinity, ATP release and sucrose density gradient fractionation, as previously described 1 . For purification of dynein from postnatal day zero (P0) brains, cytosol from three P0 brains was subjected to sucrose density gradient fractionation, microtubule-affinity in the presence of GTP (to remove kinesin), then ATP extraction to release dynein ( Supplementary  Information, Fig. S3c, d) . Biochemical assays. ATPase assays were performed using the malachite green method, as previously described 12 , in Tris-KCl buffer containing 10 mM KCl or 50 mM KCl. Assays were incubated at 37 o C for 15 min in the presence of 1 mM ATP. For ATPase activity as a function of microtubules, taxol-stabilized microtubules (Cytoskeleton) were added to a solution containing 1 μg of dynein before adding ATP to start the reaction. For ATPase activity as a function of ATP, all reactions were performed in Tris-KCl buffer containing 10 mM KCl and in the presence of 10 μM microtubules. Activities were plotted at the range of microtubule or ATP concentrations. Michaelis-Menten curves were fit to the data to derive K m and V max values.
For microtubule-binding experiments, 1 μg of dynein was incubated with taxol-stabilized microtubules at a final concentration of 2.5 μM for 15 min at 37 o C, followed by centrifugation. Supernatant and microtubule pellet were either recovered for analysis, or the pellet was resuspended in Tris-KCl buffer containing 10 mM ATP, incubated at 37 o C for 15 min, and centrifuged. Supernatants and pellets were analysed by SDS-PAGE and western blotting using antibodies against dynein intermediate chain and tubulin (1:5,000; Sigma).
Membrane flotation analysis was performed as previously described 10 . Briefly, two P0 brains from each genotype were homogenized and centrifuged at 30,000g. The supernatant was centrifuged at 150,000g. The high-speed pellet was fractionated by flotation through a 2M, 1.5M and 0.6M sucrose step gradient. Membrane vesicles floated to the 0.6-1.5M interface. Samples were taken from the 0.6M layer, the vesicle interface, and the 1.5 M layer, for SDS-PAGE, and western blot analysis using antibodies against dynein intermediate chain and heavy chain, and synaptotagmin (1:500; StressGen) as a marker for vesicles.
Quantum dot assays.
In vitro motility assays were conducted in flow chambers assembled from a glass slide and acid-washed cover slip, using double-sided adhesive tape (chamber volume, approximately 10 μl). Solutions were incubated in the chamber for 10 min. The chamber was incubated with 5 mg ml -1 biotin-BSA (bovine serum albumin), washed twice with 20 μl blocking buffer (30 mM HEPES at pH 7.2, 50 mM potassium acetate, 2 mM magnesium acetate, 1 mM EGTA (ethylene glycol tetraacetic acid), 10% (v/v) glycerol, 1 mg ml -1 BSA and 1 mg ml -1 casein), incubated with 5 mg ml -1 streptavidin solution, washed twice, then incubated with rhodamine-and biotin-labelled microtubules and washed twice again with blocking buffer containing 5 μM taxol.
Monoclonal anti-74.1 intermediate chain antibody (350 nM), polyclonal antiheavy chain antibody (450 nM) or polyclonal anti-R1B2 antibody (450 nM), were mixed with goat anti-mouse or goat anti-rabbit quantum dots (350 nM; Invitrogen) in blocking buffer for 30 min on ice. Different antibodies gave similar results. Dynein (10 nM) was added to the antibody-quantum dot mixture and incubated on ice for 30 min. Similar results were obtained at 1:50 protein:quantum dot ratios. The dynein-quantum dot mixture was diluted 50 times immediately before chamber incubation, then washed twice. Blocking buffer containing 500 μM ATP, 5 μM taxol and an oxygen scavenging solution was flowed into the chamber. Differences in run-lengths and velocities between optical trap and quantum-dot assays were because of differences in ATP concentration. Single quantum-dot-labelled-dynein molecules were visualized at 25 o C on an inverted microscope (DMIRBE, Leica) using a Qdot 525 filter set (Omega Optical). Images were captured on a CCD (charged coupled device) camera (CoolSnap HQ, Photometrics) at 5 frames s -1 . The movement of individual dynein-quantum dots was analysed using a custom-tracking program (Gross Lab) to identify the quantum dot position versus time through two dimensional Gaussian fitting of their brightness profile. A processive run is defined here as motion > 200 nm that is terminated by detachment from the microtubule. A bidirectional run is a > 200 nm run in one direction, then a > 200 nm run in the opposite direction. In the case of a bidirectional run, the run-length was measured as the sum of processive run-lengths in both directions.
Optical-trapping experiments. Optical-trap assays, data recording, particle tracking and stalling-force analysis were performed as previously described 14, [28] [29] [30] . Dynein was attached directly to polystyrene beads (PolySciences). Using antibody as a linker impaired the motility of the beads. The fraction of beads bound to microtubules was used to assess the average number of available motors per bead: 50-100% binding fractions correspond to the few motor condition, whereas ≤ 30% binding fractions correspond to the single-motor range 14, 31, 32 . Dyneincoated beads were positioned above a microtubule for 20-30 s using an optical trap. A binding event was scored on bead binding and evidence of processive motion. A sub-population of beads bound the microtubule, but did not demonstrate clear processive motion while in the trap (producing force <0.5pN). They moved bi-directionally along the microtubule once the trap was turned off at speeds independent of ATP concentration (1 versus 0.2mM ATP). These events were not biased toward mutant dynein. They were scored as binding, but were not used toward motility quantification owing to lack of normal force production. Motility and stalling force measurements were conducted using 500 nm polystyrene beads in assay buffer (10 mM PIPES, 2 mM MgSO4, 1 mM EGTA, 1 mM DTT (dithiothreitol), 50 mM potassium acetate and 10% (v/v) glycerol, at pH 6.9) supplemented with scavenging solution 33 and 1 mM ATP immediately before measurements. A custom-designed automated program monitored the bead position, then turned off the trap on detection of processive bead motion. An individual run was defined as the course between a bead binding to, and then detaching from a microtubule. For stall-force measurements, a trap stiffness of 2.2 pN per 100 nm was used. A stall was scored if the bead proceeded away from trap centre and held its plateau position for > 200 ms before detachment.
Step-size analysis was carried out on continuous segments of force traces where the systematic noise was no greater than approximately 8 nm, using an objective, model-independent, step-detection method 34 , cross verified using a chi-square reduction method 35 , and tested for kinesin stepping in vitro 36 .
Lateral position experiments were conducted using 200 nm beads 23 in assay buffer with scavenging solution and 0.2 mM ATP. We examined the lateral movement of dynein by quantifying the change in a bead's lateral position between subsequent frames. Runs longer than 200 nm and 2 s were analysed. To limit possible bias toward longer travels, runs for each genotype were grouped into five different travel ranges (increments of 100 nm from 200 to > 600 nm). The final distribution of lateral changes describes the mean ± s.d. from averaging each subgroup.
Modelling of multiple motor conditions. We adapted a recently developed Monte Carlo model that closely reproduced force measurements for multiple dyneins in vitro 16 , constrained by our experimental measurements of singlemotor processivity for dyneins from wild-type, Loa +/-, and Loa -/mice. A 'run' is initiated when at least one of the N motors becomes stochastically bound to the microtubule (characterized by on-rate), and terminated when all N motors become detached (characterized by off-rate). For each motor, we used the same dynein stiffness (0.32 pN nm -1 ), viscosity (10 -3 N s -1 per m 2 ), on-rate estimation (1/s) and step size (8 nm), as well as formulas for stepping direction, velocity and off-rate under load, as described in ref. 16 . The off-rate of dynein under no load was the lone adjusted parameter in our simulation, and was assumed to represent the sole differentiating factor between each genotype. To estimate the appropriate off-rate (under no load) for each genotype in vivo, we evaluated the average run-length in vitro when only one motor was available for transport. To account for potential in vivo factors, simulations were carried out that assumed a two-fold processivity enhancement of dynactin 18, 19 , and a 0.1 pN constant opposing force to account for viscous drag in cytosol.
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Live-cell imaging of lysosomes. Hippocampal neurons were cultured from E19 mouse embryos, as previously described, and cultured for 4-6 DIV (days in vitro) 37 . Mice were cared for and treated according to IACUC regulations. For experiments, cultures were incubated in fresh media containing 500 μM lysotracker, washed, then imaged in 2 ml of fresh media (with 10 mM HEPES) at 37 o C with 5% CO 2 , on an Olympus IX81 inverted microscope. Images were captured at 5 frames s -1 for 1.5 min using an Hamamatsu ORCA-R2 CCD camera. Experiments were performed at least three times per genotype. For velocity, the motions of single lysosomes were analysed using kymographs generated with the 'Multiple Kymograph' plug-in for ImageJ (EMBL, Germany). For run-length, individual lysosomes were identified by a 2D Gaussian fitting of their brightness profile, and custom analysis routines identified periods of uninterrupted motion (runs), where net travel for any three consecutive frames (400 ms) was at least 80 nm in the minus-end direction. (c) Simulated data was generated using 8 nm step size with experimentally determined 6 nm Gaussian noise, and three distinct velocities, the fastest of which is the experimentally determined ~700 nm/sec. Each analysis set (n = 5000) reveals primarily 8 nm steps; however, there is an increasingly prominent 16 nm peak associated with higher velocity. Figure S6 Theoretical study of multiple dynein transport using the measured in vitro processivities as the only differentiating factor between wild-type and mutant dyneins, and measurements of retrograde, lysosomal run-lengths in living neurons. (a) We simulated single dynein run-lengths for a range of dynein off-rates under no load (the only free parameter in our model, plotted points are mean ± SEM, n > 500 simulations). The resulting processivity vs. off-rate (under no load) curve is well described by a single exponential decay. (b) Based on the simulation results in (a), we chose off-rates to match the experimentally measured single-molecule in vitro processivities for each genotype, and modeled their expected multiple-motor transport both in the absence of (i), and presence of potential processivity factors present in vivo: dynactin, and viscous drag (ii). The predicted average run-lengths demonstrate amplified processivity defects in the mutants when multiple dyneins are available for transport (i, ii top). Predicted instantaneous cargo velocity (ii, middle) is not significantly affected with increasing available motor numbers, nor is it altered by Loa mutation. However, the number of instantaneously engaged motors (ii, bottom) is reduced with decreasing processivity, thus leading to further reduction in the predicted multimotor run-lengths for Loa mutants. The majority of force traces used for step-size detection correspond to the motor moving away from the trap center at ~700-800 nm/s before stalling or falling back into trap center. To gain intuition on the effect of motor velocity on step detection, we generated simulated data sets assuming 8 nm step size, 6 nm Gaussian noise (~6-8 nm measured), and three distinct velocities (corresponding to 727 nm/s, 364 nm/s, and 242 nm/s), and carried out the exact same Visscher step-detection analysis 3 . We observed an increased prominence of a 16nm peak in the detected step size distribution with increasing velocity ( Fig. S5 ), suggesting that the larger steps in Fig. S5 are artifacts of successive 8 nm steps not being resolved at the higher stepping rate. We found that this effect of combined steps at ~700 nm/sec was sufficient to account for the apparent increase in the 16nm peak in our experimentally measured step size distributions (Fig. 3c ) from that found in yeast dynein 4 .
Reduction in single motor processivity leads to reduced average cargo velocity in multiple motor transport.
For a cargo with a characteristic run-length d, at an instantaneous velocity v, and pausing duration p between detachment and re-attachment, the total distance D that the cargo can cover during the time interval T, is , and the average velocity including pauses, V, is
